Balanced news tone
News Sentiment
CLNN sentiment intelligence
Clene Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
53
Balanced news tone
40 relevant articles
News tone and price action are not far from neutral.
77/100 classification confidence.
directly relevant articles
high-authority source matches
+2.8% over one week, +7.4% over four weeks, trend active, and near fair-value range.
Enterprise value to EBIT forward of Clene Inc. – NASDAQ:CLNN
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
77/100 classification
One-week reaction
2.8%
Price confirming higher
Trend fit
Trend active
7.4% over four weeks
Fair value
-5.4%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
10
Neutral
27
Negative
3
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Market source
Direct company coverage
Clene Inc. (CLNN) Reports Q1 Loss, Misses Revenue Estimates
- Tone
- Negative 18/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- Market source
Stock Titan
Direct company coverage
Major Clene (CLNN) holder SymBiosis II, LLC sells 95,473 shares, keeps stake
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 13 May 2026 07:00
- Source
- Stock Titan
Quiver Quantitative
Direct company coverage
Clene Inc. Announces Pricing of $7 Million Registered Direct Offering of Common Stock
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 May 2026 07:00
- Source
- Quiver Quantitative
Stock Titan
Direct company coverage
Clene sells 1M shares to fund ALS drug filing and Phase 3 trial
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 May 2026 07:00
- Source
- Stock Titan
Investing.com
Direct company coverage
Clene stock tumbles after pricing $7M stock offering
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 May 2026 07:00
- Source
- Investing.com
Stock Titan
Direct company coverage
Clene lines up May 6 webcast and New York investor meetings May 7
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 May 2026 07:00
- Source
- Stock Titan
Stock Titan
Direct company coverage
Clene plans ALS drug filing after FDA says data may support faster review
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 May 2026 07:00
- Source
- Stock Titan
Stock Titan
Direct company coverage
Clene (NASDAQ: CLNN) 10% holder SymBiosis II sells 65,663 shares
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Apr 2026 07:00
- Source
- Stock Titan
Market source
Direct company coverage
When Will Clene Inc. (NASDAQ:CLNN) Turn A Profit?
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 17 Feb 2026 08:00
- Source
- Market source
MarketBeat
Direct company coverage
Clene (CLNN) Stock Price, News & Analysis
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jan 2021 13:40
- Source
- MarketBeat